Form 4 for CRL Charles River Laboratories
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-27 · accession 0001127602-22-016062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-31 | 2022-05-28+ | CRL | Knell Michael Gunnar | CAO, CSVP | F - Tax | $244.41 | -91 | 6,492 | -1% | -$22.2K |
| D | 2022-05-31 | 2022-05-27 | CRL | Knell Michael Gunnar | CAO, CSVP | A - Grant | $0.00 | +491 | 6,529 | +8% | $0 |
| D | 2022-05-31 | 2022-05-27 | CRL | Knell Michael Gunnar | CAO, CSVP | A - Grant | $244.41 | +1,327 | 1,327 | New | +$324.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-29 | F | D | 54 | $244.41 | 6,438 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-28 | F | D | 37 | $244.41 | 6,492 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-27 | A | A | 491 | $0.00 | 6,529 | D | — | — | (F1) Unvested restricted stock units vest as follows: 122 on May 27, 2023, 123 on May 27, 2024, 123 on May 27, 2025 and 123 on May 27, 2026. |
| 4 | Derivative | Stock Options (Right to Buy) | 2022-05-27 | A | A | 1,327 | $244.41 | 1,327 | D | $244.41 · 2023-05-27 to 2032-05-27 | 1,327 Common Stock | (F2) Stock Options vest as follows: 331 on May 27, 2023, 332 on May 27, 2024, 332 on May 27, 2025 and 332 on May 27, 2026. |